Suppr超能文献

应用细胞毒性药物后肿瘤细胞中3H-胸腺嘧啶核苷掺入的抑制作为治疗效果的指标(作者译)

[Inhibition of 3H-TdR-incorporation in tumor cells after application of cytotoxic drugs as an indicator of therapeutical efficacy (author's transl)].

作者信息

Possinger K, Hartenstein R, Misera C, Ehrhart H

出版信息

Blut. 1981 Aug;43(2):105-7. doi: 10.1007/BF00320469.

Abstract

In 36 Walker-ascites-carcinosarcoma bearing rats the reduction of 3H-TdR-incorporation into tumor cells after cytotoxic treatment as an potential prognostic factor for efficacy of chemotherapy was tested. Twelve rats each were i.p. treated with 1 mg/kg bw. DDP resp. 0.8 mg/kg bw. adriamycin. Twelve rats were injected with 0.2 mg phs. NaCl and served as control. Survival of rats served as criterion of therapeutic efficacy. There was a significant correlation between reduction of 3H-TdR-uptake in tumor cells after cytotoxic therapy and survival.

摘要

在36只患有沃克腹水癌肉瘤的大鼠中,测试了细胞毒性治疗后肿瘤细胞中3H-胸腺嘧啶核苷(3H-TdR)掺入量的降低作为化疗疗效潜在预后因素的情况。每组12只大鼠分别经腹腔注射1 mg/kg体重的顺铂(DDP)或0.8 mg/kg体重的阿霉素。12只大鼠注射0.2 mg的生理盐水作为对照。大鼠的存活情况作为治疗效果的标准。细胞毒性治疗后肿瘤细胞中3H-TdR摄取量的降低与存活率之间存在显著相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验